US Pharma MarketingSanofi and Wave post AATD updates in race to end genetic disease’s 40-year new treatment drought
Sanofi and Wave Life Sciences are using their time at the annual meeting of the American Thoracic Society in Orlando to share updated data for their next-gen attempts to treat a protein deficiency Sanofi and Wave Life Sciences are using their time at the annual meeting of the American Thoracic Society in Orlando to share updated data for their next-gen attempts to treat a protein deficiency disorder that hasn’t seen significant innovation in about four decades. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics…
Sanofi and Wave Life Sciences are using their time at the annual meeting of the American Thoracic Society in Orlando to share updated data for their next-gen attempts to treat a protein deficiency disorder that hasn’t seen significant innovation in about four decades.
Source: FierceBiotech